Hydroxychloroquine prophylaxis for COVID-19 contacts in India

Clicks: 374
ID: 273232
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #2 of 8 articles by views in The Lancet. Infectious Diseases

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Hydroxychloroquine prophylaxis for COVID-19 contacts in India
Reference Key
s2020thehydroxychloroquine Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Rathi S;Ish P;Kalantri A;Kalantri S;;
Journal The Lancet. Infectious Diseases
Year 2020
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/32311324
Keywords
india National Center for Biotechnology Information NCBI NLM MEDLINE covid-19 sars-cov-2 humans pubmed abstract nih national institutes of health national library of medicine Family Characteristics pneumonia betacoronavirus coronavirus infections / drug therapy coronavirus infections / prevention & control* pandemics / prevention & control* viral / prevention & control* chloroquine / therapeutic use pmid:32311324 pmc7164849 doi:10.1016/s1473-3099(20)30313-3 sahaj rathi pranav ish shriprakash kalantri chloroquine / supply & distribution contact tracing hydroxychloroquine / supply & distribution hydroxychloroquine / therapeutic use* pre-exposure prophylaxis*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.